Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 16/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.55 |
| ▸ | ESR1 | P03372 | 2/20 | 0.55 |
| ▸ | CHRM2 | P08172 | 2/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.55 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | PGR | P06401 | 2/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | MAOA | P21397 | 1/20 | 0.54 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.54 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | AR | P10275 | 1/20 | 0.51 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6695851 | 0.82 | SLC6A4 (0.57) | CYP19A1CYP2C19ESR1CHRM2SLC6A2 | |
| SCHEMBL11866158 | 0.82 | SLC6A4 (0.57) | CYP19A1CYP2C19ESR1CHRM2SLC6A2 | |
| SCHEMBL11854328 | 0.80 | ESR1 (0.52) | CYP19A1CYP2C19ESR1CHRM2SLC6A2 | |
| SCHEMBL7862313 | 0.80 | CYP19A1 (0.46) | CYP19A1 | |
| SCHEMBL11632217 | 0.80 | CYP19A1 (1.00) | CYP19A1CYP2C19ESR1SLC6A4PGR | |
| SCHEMBL21807725 | 0.80 | CYP19A1 (1.00) | CYP19A1CYP2C19ESR1SLC6A4PGR | |
| SCHEMBL16387354 | 0.80 | CYP19A1 (1.00) | CYP19A1CYP2C19ESR1SLC6A4PGR | |
| SCHEMBL868884 | 0.80 | CYP19A1 (1.00) | CYP19A1CYP2C19ESR1SLC6A4PGR | |
| SCHEMBL17831183 | 0.80 | CYP19A1 (1.00) | CYP19A1CYP2C19ESR1SLC6A4PGR | |
| SCHEMBL12413521 | 0.80 | CYP19A1 (1.00) | CYP19A1CYP2C19ESR1SLC6A4PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115448969-B | Refining method of desogestrel | 上海格苓凯生物科技有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-115448969-A | Refining method of desogestrel | 上海格苓凯生物科技有限公司 | 2022-12-09 | — | — | CN | claimed |
| WO-2024237614-A1 | JAPANESE KEYBOARD AND JAPANESE INPUT METHOD | 이학준 | 2024-11-21 | — | — | WO | disclosed |
| CN-115448969-B | Refining method of desogestrel | 上海格苓凯生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-115448969-B | Refining method of desogestrel | 上海格苓凯生物科技有限公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-115448969-A | Refining method of desogestrel | 上海格苓凯生物科技有限公司 | 2022-12-09 | — | — | CN | disclosed |
| US-20220089637-A1 | STEROID COMPOUND, AND USE THEREOF AND PREPARATION METHOD THEREFOR | Chengdu kanghong pharmaceutical co ltd (CN) | 2022-03-24 | — | — | US | disclosed |
| EP-0709394-B1 | Steroids with a 17-spiromethylene lactone or lactol group | AKZO NOBEL NV (NL) | 2001-01-31 | — | — | EP | disclosed |
| US-5741786-A | PROGESTATIONAL ACTIVITY, USED AS CONTRACEPTIVES | AKZO NOBEL N.V. (NL) | 1998-04-21 | — | — | US | disclosed |
| EP-0709394-A2 | Steroids with a 17-spiromethylene lactone or lactol group | Akzo Nobel N.V. (NL) | 1996-05-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089637-A1 | STEROID COMPOUND, AND USE THEREOF AND PREPARATION METHOD THEREFOR | CYP11B1, CYP4A11, CYP11B2 | CYP19A1 31/4885CYP2C19 46/4885ESR1 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.